Search for: "Manual Enterprises, Inc. v. Day" Results 41 - 51 of 51
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Sep 2009, 1:47 pm
(Millbury, MA; Eric Conlon, President) Bandjo Enterprises, Inc.. [read post]
13 Feb 2009, 8:00 am
(IP Think Tank) (The IP ADR Blog) (Chicago Intellectual Property Law Blog) 50 years of scientific discovery and sharing in Antarctica may end thanks to patent greed (Techdirt) Take steps to limit the impact of licensee’s economic woes (Technology Transfer Tactics)   Australia TMO delegate allows ‘ElvisFinance’ covering financial services to proceed to registration despite opposition: Elvis Presley Enterprises Inc v Elvis Jelcic… [read post]
18 Oct 2008, 11:33 pm
Hearing at St Louis, 16 days between Aug. 4, 2003 and Feb. 5, 2004. [read post]
19 Sep 2008, 6:00 pm
: (Ars Technica), Google, GE join forces for green tech research, lobbying: (Ars Technica), AIPPI Congress: how to protect you IP rights in virtual worlds (Managing Intellectual Property), Industry still wary of ICANN plan for new top-level internet domains: (Intellectual Property Watch), Ubuntu-Firefox EULA dustup reignites OSS licensing debate: (Ars Technica), Media standard backers attempt Apple-less solo run: (Out-Law), Open Source in Mobile conference: OpenMoko CEO says embrace fragmentation,… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]